Author:
Chen Yingtong,Yang Ping,Wang Jing,Zhu Mingxia,Wang Yanfang,Gao Shuang,Zhang Weilong,Ke Xiaoyan,Jing Hongmei
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference47 articles.
1. Maddocks K. Update on mantle cell lymphoma;Blood,2018
2. Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management;P Jain;Am J Hematol,2019
3. Mantle cell lymphoma: insights into therapeutic targets at the preclinical level;P Klener;Expert Opin Ther Targets,2020
4. Treatment of Patients with Relapsed or Refractory Mantle-Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase;Y Song;Clin Cancer Res,2020
5. Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma;M Dreyling;Ann Oncol,2017